Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia

Journal of the American Academy of Dermatology

Volumn 69, Issue 5, 2013, Pages 839-840

  Delgado, Livia ^a   Giraudier, Stephane ^a   Ortonne, Nicolas ^a   Zehou, Ouidad ^a   Cordonnier, Catherine ^a   Hulin, Anne ^a   Chosidow, Olivier ^a   Tulliez, Michel ^a   Valeyrie Allanore, Laurence ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885633547     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.07.025     Document Type: Article

References (6)

1. L. Valeyrie, S. Bastuji-Garin, J. Revuz, N. Bachot, J. Wechsler, and P. Berthaud Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients J Am Acad Dermatol 48 2003 201 206
2. G. Saglio, A. Hochhaus, Y.T. Goh, T. Masszi, R. Pasquini, and F. Maloisel Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily Cancer 116 2010 3852 3861
3. H.M. Kantarjian, F.J. Giles, K.N. Bhalla, J. Pinilla-Ibarz, R.A. Larson, and N. Gattermann Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results Blood 117 2011 1141 1145
4. B. Belloni, N. Schonewolf, S. Rozati, S.M. Goldinger, and R. Dummer Cutaneous drug eruptions associated with the use of new oncological drugs Chem Immunol Allergy 97 2012 191 202
5. Y. Liu, M. Karaca, Z. Zhang, D. Gioeli, H.S. Earp, and Y.E. Whang Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases Oncogene 29 2010 3208 3216
6. Cancer therapy evaluation program. Common toxicity criteria, version 2.0 March 1998 National Cancer Institute Bethesda, MD